The estimated Net Worth of Feng Peng is at least $523 Thousand dollars as of 28 April 2021. Mr. Peng owns over 426 units of Usana Health Sciences Inc stock worth over $28,146 and over the last 8 years he sold USNA stock worth over $293,815. In addition, he makes $201,396 as Independent Director at Usana Health Sciences Inc.
Sign up
Mr. Peng USNA stock SEC Form 4 insiders trading
Feng has made over 13 trades of the Usana Health Sciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 426 units of USNA stock worth $15,881 on 28 April 2021.
The largest trade he's ever made was selling 852 units of Usana Health Sciences Inc stock on 10 February 2021 worth over $80,608. On average, Feng trades about 242 units every 40 days since 2017. As of 28 April 2021 he still owns at least 755 units of Usana Health Sciences Inc stock.
You can see the complete history of Mr. Peng stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Feng Peng biography
Feng Peng is an Independent Director of the Company. Audit Committee, Compensation Committee and Governance, Risk & Nominating Committee member. Mr. Peng was elected to the Board in May 2, 2016. Mr. Peng has served as a Partner and Portfolio Manager at Linden Rose Investment LLC (LRI) since January 2017. LRI is a value-focused investment firm based in Texas and New Jersey. From March 2013 to December 2016, Mr. Peng served as Chief Financial Officer of Ossen Innovation Co., Ltd. (NASDAQ:OSN), a Chinabased manufacturing company. Prior to that, Mr. Peng served as Senior Vice President at MZ Group from August 2007 until September 2012 where he was responsible for providing strategic consulting services related to U.S. capital markets to Chinese clients. At MZ Group, Mr. Peng conducted extensive financial and industry due diligence, performed analysis on companies' financials, and provided management teams of client companies with extensive coaching, including detailed intelligence on investor expectations, perceptions and concerns, industry analysis, compliance, and reporting and disclosure requirements. Prior to working at MZ Group, he served in various capacities at Thomson Financial and Citigroup. Mr. Peng has been trained in both finance and accounting. He received a Master of Science in Computer Science from the New Jersey Institute of Technology. He also received a bachelor's degree in Automation Control from Shanghai Jiao Tong University in Shanghai, China in 1995. Mr. Peng is a certified Senior International Finance Manager (SIFM) in China. Mr. Peng's qualifications to sit on our Board include his extensive business experience in China, as well as his financial and corporate strategy experience.
What is the salary of Feng Peng?
As the Independent Director of Usana Health Sciences Inc, the total compensation of Feng Peng at Usana Health Sciences Inc is $201,396. There are 16 executives at Usana Health Sciences Inc getting paid more, with Kevin Guest having the highest compensation of $4,157,830.
How old is Feng Peng?
Feng Peng is 46, he's been the Independent Director of Usana Health Sciences Inc since 2016. There are 20 older and 3 younger executives at Usana Health Sciences Inc. The oldest executive at Usana Health Sciences Inc is Dr. Myron W. Wentz, 80, who is the Founder & Chairman Emeritus.
What's Feng Peng's mailing address?
Feng's mailing address filed with the SEC is 3838 WEST PARKWAY BLVD, , SALT LAKE CITY, UT, 84121.
Insiders trading at Usana Health Sciences Inc
Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull, and Myron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.
What does Usana Health Sciences Inc do?
usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su
What does Usana Health Sciences Inc's logo look like?
Complete history of Mr. Peng stock trades at Usana Health Sciences Inc
Usana Health Sciences Inc executives and stock owners
Usana Health Sciences Inc executives and other stock owners filed with the SEC include:
-
Kevin Guest,
Chairman of the Board, Chief Executive Officer -
Jim Brown,
President -
Kevin G. Guest,
Chairman & CEO -
G Hekking,
Chief Financial Officer -
David Mulham,
Chief Field Development Officer -
Walter Noot,
Chief Operating Officer -
Jim Brown,
Pres -
Daniel Macuga,
Chief Communications and Marketing Officer -
G. Douglas Hekking,
Chief Financial Officer -
David Mulham,
Chief Sales Officer -
Walter Noot,
Chief Operating Officer -
Paul Jones,
Chief Leadership Development Officer -
Peggie Pelosi,
Independent Director -
Gilbert Fuller,
Lead Independent Director -
Robert Anciaux,
Senior Director -
Frederic Winssinger,
Independent Director -
Feng Peng,
Independent Director -
Timothy Wood,
Independent Director -
Dr. Myron W. Wentz,
Founder & Chairman Emeritus -
John Fleming,
Director -
Brent Neidig,
Chief Officer and Managing Director of China -
P. Joshua Foukas,
Chief Legal Officer, General Counsel and Corporate Secretary -
Robert Sinnott,
Chief Scientific Officer -
P. Joshua Foukas,
Chief Legal Officer, Gen. Counsel & Corp. Sec. -
Patrique Richards,
Exec. Director of Investor Relations & Bus. Devel. -
Dr. John Cuomo,
Exec. Director of Product Devel. & Technology -
J Scott Nixon,
Director -
Myron W Gull Global Ltd Wentz,
-
Robert Auciaux,
-
Global Ltd Gull,
10% owner -
Myron W Wentz,
CEO -
Deborah Woo,
E.V.P. of Sales -
Donald R. Williams,
Director -
Dave Wentz,
President -
James Bramble,
-
Jerry G Mcclain,
Director -
Denis E Waitley,
Director -
Roy Truett,
Chief Information Officer -
Doug Braun,
Chief Marketing Officer -
Ronald S Poelman,
Director -
Rick Stambaugh,
Chief Information Officer -
Holdings Ltd Gull,
10% owner -
Fred W Cooper,
Vice President of Operations -
Jeffrey Yates,
Chief Financial Officer -
Mark H Wilson,
V.P. of Customer Relations -
Bradford Richardson,
E.V.P. of Asia Pacific -
G Doug Iiekking,
CHIEF FINANCIAL OFFICER -
Peter Benedict,
CHIEF INFORMATION OFFICER -
Joshua Foukas,
CHIEF LEGAL OFFICER -
Xia Ding,
Director